1. Dermatology Partnering Terms and Agreements
The Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis of
how and why companies enter dermatology partnering deals. The majority of deals are discovery, preclinical
or development stage whereby the licensee obtains a right or an option right to license the licensors bacterials
technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization
of outcomes.
This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight
into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst
many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of
how payments are triggered – contract documents provide this insight where press releases and
databases do not.
The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront
payment, milestone payments and royalty rates. The initial chapters of this report provide an orientation of
dermatology dealmaking and business activities.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in dermatology dealmaking since 2007 covering trends by year,
deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes
an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone
payments and royalty rates. Analysis includes median values and distribution of values for each stage of
development.
Chapter 3 provides a review of the leading dermatology deals since 2007. Deals are listed by headline value,
signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has
an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary
followed by a comprehensive listing of dermatology deals, as well as contract documents available in the
public domain. Where available, each deal title links via Weblink to an online version of the actual contract
document, providing easy access to each contract document on demand.
Chapter 5 provides comprehensive access to all dermatology deals since 2007 where a deal contract is
available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each
deal title links via Weblink to an online version of the deal record contract document, providing easy access to
each contract document on demand.
Chapter 6 provides a comprehensive directory of all dermatology partnering deals signed and announced
since 2007. The chapter is organized by specific dermatology therapy focus. Each deal title links via Weblink
to an online version of the deal record and where available, the contract document, providing easy access to
each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed
and announced since 2007. The appendices are organized by company A-Z, stage of development at signing,
deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via
Dermatology Partnering Terms and Agreements

2. Weblink to an online version of the deal record and where available, the contract document, providing easy
access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in dermatology
partnering and dealmaking since 2007.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of dermatology technologies and products.
Key benefits Dermatology Partnering Terms and Agreementsprovides the reader with the following key
benefits:
In-depth understanding of dental deal trends since 2007 Access dental deal headline, upfront, milestone and
royalty data Research hundreds of actual contracts between dermatology partner companies Comprehensive
access to over 1500 links to actual dermatology deals entered into by the world’s biopharma companies
Indepth review of dental deals entered into by the leading fifty bigpharma companies Benchmark the key deal
terms companies have agreed in previous deals Identify key terms under which companies partner
dermatology opportunities Uncover companies actively partnering dermatology opportunities Report scope
Dermatology Partnering Terms and Agreements is intended to provide the reader with an in-depth
understanding and access to dermatology trends and structure of deals entered into by leading companies
worldwide.
Dermatology Partnering Terms and Agreements includes:
Trends in dermatology dealmaking in the biopharma industry since 2007 Analysis of dermatology deal
structure Access to headline, upfront, milestone and royalty data Access to hundreds of dermatology deal
contract documents Comprehensive access to over 1500 dermatology deal records The leading dermatology
deals by value since 2007 Most active dermatology dealmakers since 2007
In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by:
Headline value o Upfront payment value Royalty rate value o Stage of development at signing Deal
component type Technology type Specific therapy indication Each deal title links via Weblink to an online
version of the deal record and where available, the contract document, providing easy access to each contract
document on demand.
table Of Contents
executive Summary
chapter 1 – Introduction
chapter 2 – Trends In Dermatology Dealmaking
2.1. Introduction
2.2. Dermatology Partnering Over The Years
2.3. Bigpharma Dermatology Dealmaking Activity
2.4. Bigpharma Not Active In Dermatology
2.5. Dermatology Partnering By Deal Type
Dermatology Partnering Terms and Agreements

3. 2.6. Dermatology Partnering By Industry Sector
2.7. Dermatology Partnering By Stage Of Development
2.8. Dermatology Partnering By Technology Type
2.9. Dermatology Partnering By Dermatology Indication
2.10. Average Deal Terms For Dermatology
2.10.1 Dermatology Headline Values
2.10.2 Dermatology Upfront Payments
2.10.3 Dermatology Milestone Payments
2.10.4 Dermatology Royalty Rates
chapter 3 – Leading Dermatology Deals
3.1. Introduction
3.2. Top Dermatology Deals By Value
3.3. Top Dermatology Deals Involving Bigpharma
chapter 4 – Bigpharma Dermatology Deals
4.1. Introduction
4.2. How To Use Bigpharma Partnering Deals
4.3. Bigpharma Dermatology Partnering Company Profiles
abbott
actavis
actelion
allergan
amgen
astellas
astrazeneca
baxter International
bayer
bristol-myers
squibb C
elgene
eli Lilly
endo Pharmaceuticals
forest Laboratories
galderma
glaxosmithkline
hospira
johnson & Johnson
merck & Co
merck Kgaa
mitsubishi Tanabe
novartis
pfizer
Dermatology Partnering Terms and Agreements

4. roche
sanofi
shionogi
shire
teva
warner Chilcott
watson
chapter 5 – Dermatology Partnering Contracts Directory
5.1. Introduction
5.2. By Deal Type
asset Purchase
assignment
bigpharma Outlicensing
co-development
collaborative R&d
co-market
contract Service
co-promotion
development
distribution
equity Purchase
joint Venture
licensing
litigation
loan
manufacturing
marketing
option
promotion
research
settlement
sub-license
supply
termination
5.3. By Stage Of Development
discovery
formulation
marketed
phase I
phase Ii
phase Iii
Dermatology Partnering Terms and Agreements

5. preclinical
5.4. By Technology Type
antibodies
assays
biologicalcompounds
biomaterials
clinical Testing
devices
diagnostics
dna Probes
drug Delivery
enabling Technology
equipment
genomics
natural Product
oligonucleotide
orphan Drug
peptides
processes
recombinant Dna
regenerative Medicine
research Services
research Supplies
screening
small Molecules
stem Cells
chapter 6 – Dermatology Dealmaking By Indication
6.1. Introduction
6.2. Deals By Therapeutic Indication
dermatology
acne
actinickeratosis
angioedema
burns
cellulitis
cosmetics
dermatitis
diabetic Foot Ulcer
eczema Hair Disorders
impetigo
itching
nail Disorders
Dermatology Partnering Terms and Agreements

6. psoriasis Rosacea
sun Damage
rash Scar
venous Ulcer
wound Healing
wrinkles
chapter 7 – Partnering Resource Center
7.1. Online Partnering
7.2. Partnering Events
7.3. Further Reading On Dealmaking
appendices
appendix 1 – Directory Of Dermatology Deals By Company A-z 2007-2012
appendix 2 – Directory Of Dermatology Deals By Deal Type 2007-2012
asset Purchase
assignment
bigpharma Outlicensing
co-development
collaborative R&d
co-market
contract Service
co-promotion
crada
cross-licensing
development
distribution
equity Purchase
evaluation
grant
joint Venture
licensing
litigation
loan
manufacturing
manufacturing - Oem
marketing
material Transfer
option
promotion
research
royalty Financing
Dermatology Partnering Terms and Agreements

7. settlement
spin Out
sub-license
supply
technology Transfer
termination
warranty
appendix 3 - Directory Of Dermatology Deals By Stage Of Development 2007-2012
appendix 4 – Directory Of Dermatology Deals By Technology Type 2007
appendix 5 – Deal Type Definitions
about Wildwood Ventures
current Partnering
current Agreements
recent Titles From Currentpartnering
order Form – Reports
About Us:
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of
Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
ResearchMoz
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Blog: http://researchmoz.blogspot.com/
Website: http://www.researchmoz.us/
Dermatology Partnering Terms and Agreements